89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Portfolio Pulse from
89bio, Inc. has announced the upsized pricing of its $125 million public offering of common stock and pre-funded warrants. The offering includes 11,455,882 shares at $8.50 each and pre-funded warrants for 3,250,000 shares at $8.499 each. The offering is expected to close on November 14, 2024.
November 13, 2024 | 5:15 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
89bio, Inc. has announced an upsized public offering of $125 million, which includes common stock and pre-funded warrants. This move is likely to impact the stock price as it increases the number of shares available in the market.
The announcement of an upsized public offering typically leads to a short-term decrease in stock price due to dilution, as more shares are introduced into the market. The offering is significant at $125 million, indicating a substantial increase in available shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100